Items where authors include "Gore, M"

Article

Gore, M, Hackshaw, A, Brady, WE et al. (19 more authors) (2019) An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor. Gynecologic Oncology, 153 (3). pp. 541-548. ISSN 0090-8258

Bridgeman, VL, Vermeulen, PB, Foo, S et al. (19 more authors) (2017) Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. The Journal of Pathology, 241 (3). pp. 362-374. ISSN 0022-3417

Bridgeman, VL, Wan, E, Foo, S et al. (12 more authors) (2016) Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma. Molecular Cancer Therapeutics, 15 (1). pp. 172-183. ISSN 1535-7163

Bojesen, SE, Pooley, KA, Johnatty, SE et al. (442 more authors) (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics, 45 (4). pp. 371-384. ISSN 1061-4036

Hall, M, Gourley, C, Mcneish, I et al. (6 more authors) (2013) Targeted anti-vascular therapies for ovarian cancer: Current evidence. British Journal of Cancer, 108 (2). pp. 250-258. ISSN 0007-0920

Harries, M, Moss, C, Perren, T orcid.org/0000-0001-8472-8856 et al. (10 more authors) (2004) A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer. British Journal of Cancer, 91 (4). pp. 627-632. ISSN 0007-0920

Perren, TJ orcid.org/0000-0001-8472-8856, Wiltshaw, E, Harper, P et al. (6 more authors) (1993) A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. British Journal of Cancer, 68 (6). pp. 1190-1194. ISSN 0007-0920

Selby, P, Patel, P, Milan, S et al. (7 more authors) (1990) ChlVPP combination chemotherapy for Hodgkin's disease: long-term results. British Journal of Cancer, 62 (2). pp. 279-285. ISSN 0007-0920

Zulian, GB, Selby, P, Milan, S et al. (5 more authors) (1989) High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin’s disease. British Journal of Cancer, 59 (4). pp. 631-635. ISSN 0007-0920